Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432835 · ClinicalTrials.gov registry record · Phase 3
Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis
A Phase 3 study, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 58
- Enrollment target
NCT00432835 is a Phase 3 study that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 58 participants.
The verdict
NCT00432835, a Phase 3 study, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this research is to determine if temporary gastric electrical stimulation will help improve symptoms of gastroparesis (abnormal stomach emptying). We hypothesize that when the device is ON, Gastrointestinal symptoms will decrease by at least 50% from baseline.
Interventions
- DEVICE Gastric Electrical Stimulator, Enterra, Medtronics, Inc.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00432835
The ClinicalTrials.gov registry entry for NCT00432835 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gastric Electrical Stimulator, Enterra, Medtronics, Inc. is the first listed.
NCT00432835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00432835 about?
NCT00432835 is a clinical study titled "Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis". The purpose of this research is to determine if temporary gastric electrical stimulation will help improve symptoms of gastroparesis (abnormal stomach emptying). We hypothesize that when the device is ON, Gastrointestinal symptoms will decrease by at least 50% from baseline.
What is the current status of trial NCT00432835?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 58 participants. The study started on 2005-08. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00432835?
The interventions under investigation include: Gastric Electrical Stimulator, Enterra, Medtronics, Inc. (DEVICE).
Who is sponsoring clinical trial NCT00432835?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.